Small non-coding RNAs transfer through mammalian placenta and directly regulate fetal gene expression

References

[1] Atreya CD, Mohan KV, Kulkarni S (2004) Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level. Birth Defects Research Part A Clin Mol Teratol70: 431-437

[2] Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116: 281-297

[3] Brogly SB, DiMauro S, Van Dyke RB, Williams PL, Naini A, Libutti DE, Choi J, Chung M, Gerschenson M (2011) Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. AIDS Res Hum Retroviruses27: 777-783

[4] Castellsague X, Drudis T, Canadas MP, Gonce A, Ros R, Perez JM, Quintana MJ, Munoz J, Albero G, de Sanjose S (2009) Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis9: 74

[5] Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res18: 997-1006

[6] Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H (2012) Pathogenesis of hepatitis C during pregnancy and childhood. Viruses4: 3531-3550

[7] Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X, Yin Y, Wang Q, Xue Y, Wang C (2013) Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J Biol Chem288: 23586-23596

[8] Liu Y, Zhao L, Li D, Yin Y, Zhang CY, Li J, Zhang Y (2013) Microvesicle-delivery miR-150 promotes tumorigenesis by upregulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein Cell 4: 932-941

[9] Mizejewski GJ (2004) Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp Biol Med229: 439-463

[10] Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet2: 538-548

[11] Soilleux EJ, Morris LS, Lee B, Pohlmann S, Trowsdale J, Doms RW, Coleman N (2001) Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol195: 586-592

[12] van den Boorn JG, Schlee M, Coch C, Hartmann G (2011) SiRNA delivery with exosome nanoparticles. Nat Biotechnol29: 325-326

[13] van der Aa EM, Peereboom-Stegeman JH, Noordhoek J, Gribnau FW, Russel FG(1998) Mechanisms of drug transfer across the human placenta. Pharm World Sci20: 139-148

[14] Watson ED, Cross JC (2005) Development of structures and transport functions in the mouse placenta. Physiology20: 180-193

[15] Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell39: 133-144

[16] Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, Li J, Bian Z, Liang X, Cai X (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res22: 107-126

[17] Zhang Y, Li L, Yu J, Zhu D, Zhang Y, Li X, Gu H, Zhang CY, Zen K (2014) Microvesicle-mediated delivery of transforming growth factor beta1 siRNA for the suppression of tumor growth in mice. Biomaterials35: 4390-4400

[18] Zhou Z, Li X, Liu J, Dong L, Chen Q, Liu J, Kong H, Zhang Q, Qi X, Hou D (2015) Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses. Cell Res25: 39-49

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.